{"cdcTestId":"2013-0116","testcaseName":"dose 2 to 3 Pediarix, interval 28-4 days.","vaccineGroup":"DTAP","evaluationTestType":"Interval: At Absolute Minimum","forecastTestType":"Recommended based on age","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2022-05-25T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-07-25T00:00:00","vaccineName":"PEDIARIX","cvx":"110","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-09-25T00:00:00","vaccineName":"PEDIARIX","cvx":"110","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"PEDIARIX","cvx":"110","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"4","earliestDate":"2023-08-25T00:00:00","recommendedDate":"2023-08-25T00:00:00","pastDueDate":"2024-01-21T00:00:00"},"doses":[{"dateAdministered":"2022-07-25T00:00:00","vaccineName":"PEDIARIX","cvx":"110","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-09-25T00:00:00","vaccineName":"PEDIARIX","cvx":"110","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"PEDIARIX","cvx":"110","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2020-08-17T16:14:49.688","generalDescription":"This test case describes when a child is administered dose three of the DTaP vaccine (Pediarix) at an interval of 28 -4 days after the second dose that the dose is valid.  Another dose should be forecast.","changedInVersion":"3.3","reasonForChange":"Updated per the 2017 General Best Practice Guidelines which moved the Minimum and Recommended Age to 15 months"}